19. December 2013. Bio-engineering, neurotechnology and the importance of neuroethics. Plenary lecture: Division of Mechatronics, Munich University of Applied Sciences, Munich, GER.
17. December 2013. Neuroethics – Navigating the good, the needed and the nasty of neuroscience in society. Public Plenary Lecture: Coburg University of Applied Arts and Sciences, Coburg, GER.
17. December 2013. Neurotechnologies for health promotion: Benefits, burdens and the need for neuroethics. Department of Integrative Health Promotions. Coburg University of Applied Arts and Sciences, Coburg, GER.
15. November 2013. Imaging pain: Technical capabilities; neuroethical issues. Sigma Xi Distinguished Lecture, A.T Still University of Health Sciences, Kirksville, MO.
14. November 2013. BRAIN: A “feet on the ground” view of global initiatives in neurotechnology. Plenary: Strategic Multilevel Assessment Group 8th Annual Conference on Strategic Initiatives. US Joint Base Andrews, MD.
25. October 2013. Brave new BRAIN: National agendas in neuroscience and the need for neuroethics. Distinguished Lecture: “Discoveries” Public Lecture Series, Georgetown University, Washington, DC.
18. October 2013. Neuroecology, neuroscience and neurotechnology in programs of international influence and violence deterrence. Plenary, and Conference Co-chair. US Department of Health and Human Services’ Conference on Neuro-influence and Neuro-deterrence. Washington, DC
19. September 2013. Bioscience as demiurge: Homo-biotechnicus and technology revisited. Plenary: National Academy of Sciences’ DC Arts and Sciences Evening Rendezvous, Washington, DC.
21. August 2013. Neuro-cyber technologic fusion, preparedness and neuroethics. Plenary: First Annual conference on Human-Cyber Fusion. L’Enfant Plaza, Washington, DC
6. August 2013. Brave new BRAIN: “Neuro-technology” redux and neuroethical responsibilities. Invited lecture: National Science Foundation Café Scientifique, Arlington, VA.
23. July 2013. Neuroweapons and neuroethics in national security and defense. Plenary: American Association for the Advancement of Science Neuroscience and Ethics conference; Washington, DC.
19. July 2013. Brave new brain? Neuroscience, neuroculture and neuroethics. National LeadAmerica Educational Program in Science, Technology and Medicine: Columbia University, NY.
14. July 2013. Neuroscience, society and the importance of neuroethics. Invited lecture: National LeadAmerica Educational Program in Science, Technology and Medicine; Johns Hopkins University, Baltimore, MD
12. July 2013. Me, machine and morality: Science, cyborgization and 21st century society. National LeadAmerica Educational Program in Science, Technology and Medicine: Columbia University, NY
11. July 2013. Brave new brain? Neuroscience, neuroculture and neuroethics. National LeadAmerica Educational Program in Science, Technology and Medicine: Columbia University, NY.
4. July 2013. Brain science, technology and the future of humanity. Progress, problems and neuroethical obligations. Plenary: National Youth Leadership forum, Washington, DC.
28. June 2013. Cyborgization and the cyborg society. Invited lecture: National LeadAmerica Educational Program in Science, Technology and Medicine; Johns Hopkins University, Baltimore, MD.
27. June 2013. Neuroscience, society and the importance of neuroethics. Invited lecture: National LeadAmerica Educational Program in Science, Technology and Medicine; Johns Hopkins University, Baltimore, MD.
24. June 2013. Neuroethics- at the intersection of science, society and morality. Plenary: National Youth Leadership forum, Washington, DC.
10. June 2013. Battlescape brain: Weaponizable Neurotechnologies and the need for neuroethics. Plenary: US Naval War College, Newport, RI.
9. June 2013. Neurotechnology and neuroethical promise- and problems – in pediatric pain research and therapeutics. Plenary: Second International Conference on Opioids, Harvard University Medical School, Boston, MA.
5. June 2013. The neuroscience of pediatric pain, and the neuroethics of pediatric pain care. Invited lecture: Childrens’ Hospital and Clinics of Minnesota; Pain Master Class, Minneapolis, MN.
23. May 2013. Neurotechnology- treatment, enablement and enhancement: Neuroethical implications for the deaf community. Invited plenary: Munich University of Applied Sciences, Munich, GER.
10. May 2013. Brain Research – The good, the bad, the ugly – and need for neuroethics. Invited lecture: President’s Commission for the Study of Bioethical Issues, Washington, DC
7. May 2013. Frontier science and the responsible conduct of research: Implications for specialized populations. Plenary: Annual Symposium on Research Ethics; Gallaudet University, Washington, Dc.
3. May 2013. Neuroscience, neurotechnology and the neurophilosophy and neuroethics of the human person. Invited lecture: Krok Foundation Conference on Science, Persons and Morality. University of Notre Dame, IN.
29. April 2013. Dual use issues in neuroscience and the role of neuroethics education, training and practices. Invited lecture: Science, Security and Policy Studies Group, American Association for the Advancement of Science (AAAS), Washington, DC.
26. April 2013. Neuroscience: trajectories, valences and the need for neuroethics. Plenary; North Dakota Academy of Sciences, Grand Forks, ND.
13. April 2013. Neuroethics: Two traditions and the viability of a naturalistic meta-ethics. Invited lecture: “The Human Prospect Conference”, Columbia University, NY.
2. April 2013. A right and good healing: Philosophical and ethical bases of an integrative medicine. Plenary: Medical Humanities Program, University of Texas Medical Branch, Galveston, TX.
1. April 2013. Predictive neuroscience: Possibilities and challenges – and the importance of neuroethics. Invited lecture: John McGovern Center for Health, Humanities and Ethics, University of Texas Health Sciences Center, Houston, TX.
1. April 2013. Systems neuroscience, integrative convergence and pragmatic neuroethics. Invited lecture: Systems and Complexity Studies Program, Dept of Graduate Nursing, University of Texas Health Sciences Center, Houston. Houston, TX.
22. Mar. 2013. Neuroethics – at the intersection of mind, machines and morality. Plenary: Shenandoah Science and Technology Symposium, Harrisburg, VA.
9. Feb. 2013. Predictive neurotechnologies: Facts, fictions and fears of scanning brains and reading minds. Invited lecture; National Capital Association of Skeptics- National Science Foundation, Arlington, VA
29 Jan. 2013. Battlescape Brain: Neuroweapons and the Neuroethics of National Security and Defense. AAAS Fellows Neuroscience Policy Affinity Group.
25 Jan. 2013.Neuroscience: The Good, the Bad, the Ugly, and the Need for Neuroethics. Keynote lecture McGill University Academia Week, Montreal, Canada.
20. Dec. 2012. Human-machine interfacing: Bioengineering the ‘weak link’ out of high performance aircraft flight. Invited lecture: Luftfahrtssystems’ Abteilung; Engineering Directorate, Technisches Universität München, GER.
7. Nov. 2012. Neurotechnology: Capabilities, limitations and applications in national security and defense. Invited lecture: Pentagon Strategic Multi-level Assessment Group Annual Conference: “Neurobiology in National Security”. Joint Base Andrews, MD.
18. Oct 2012. Neurotechnology, neuroart, and the need for neuroethics. Plenary: “Brain Sciences and the Cyborg – Part 2: Science, Art, Ethics and Policy”. National Academy of Sciences’ DC Arts and Sciences Evening Rendezvous (DASER), National Academy of Sciences, Washington, DC.
20. Sept 2012. Neuroscience and neuroculture: Traction and tensions at the interface of brain science and cyborgization. Plenary: National Academy of Sciences’ DC Arts and Sciences Evening Rendezvous (DASER), National Academy of Sciences, Washington, DC.
15. Sept 2012. Neuroscience, neurotechnology and neuroethics: Addressing the good, the bad and the ugly. Plenary: National Academy of Sciences-Science and Entertainment Exchange (NAS-SEE) Conference on “Science Friction – The Cutting Edge of Science in Society”, California Science Center, Los Angeles, CA.
29. Aug 2012. From the neurobiology of pain to a neuroethics of pediatric pain care. Invited lecture: Grand Rounds, Children’s Hospitals and Clinics of Minnesota, Minneapolis, MN.
7. Aug 2012. Conscious machine? Possible trajectories and the importance of neuro– robo - ethics. Invited lecture: National Science Foundation, Café Scientifique, Arlington, VA.
27. July 2012. Cybernetics and cyborgization: Technology, and the realities of human evolution. Invited lecture: National LeadAmerica Educational Program in Science, Technology and Medicine, Columbia University, NY, NY.
26. July 2012. Neuroethics: Issues at the intersection of brain science and society. Invited lecture: National LeadAmerica Educational Program in Science, Technology and Medicine, Columbia University, NY, NY.
25. July 2012. Sentient machines, and machine-selves: The new frontier of neuro-cybersciences. Invited lecture: National LeadAmerica Educational Program in Science, Technology and Medicine, Johns Hopkins University, Baltimore MD.
24. July 2012. Neuroscience, neurotechnology and ethics: Moral, social and legal issues at the convergence of man, minds and machines. Invited lecture: National LeadAmerica Educational Program in Science, Technology and Medicine, Johns Hopkins University, Baltimore MD.
13. July 2012. Cybernetics and cyborgization: Technology, and the realities of human evolution. Invited lecture: National LeadAmerica Educational Program in Science, Technology and Medicine, Johns Hopkins University, Baltimore MD.
12. July 2012. Neuroethics: Issues at the intersection of brain science and society. Invited lecture: National LeadAmerica Educational Program in Science, Technology and Medicine, Johns Hopkins University, Baltimore MD.
5. July 2012. Neural implants and indwelling neurotechnologies: Treatments, enhancements or enablements? Plenary: Second Annual Conference on Neuroethics, International University of Rome and Universita Apostolorum, Rome, Italy.
4. July 2012. Neurobioethics: Defining the field, discipline and its practice. Plenary: Second Annual Conference on Neuroethics, International University of Rome and Universita Apostolorum, Rome, Italy.
15. June 2012. The neuroscience of pediatric pain and the neuroethics of pediatric pain care. Keynote: Pain Master Class Symposium; Childrens’ Hospital and Clinics of Minnesota, Minneapolis, MN.
11. June 2012. Neuroethical issues in pain therapeutics: Implications for opioid development and use. Plenary lecture, and session chair: First International conference on opioids. Harvard Medical School, Boston, MA.
16. May 2012. Toward a practical ethical framework for decision-making in disaster management. Session chair; FEMA Conference on Improvised Nuclear Devices; Washington, DC.
15. May 2012. Predictive neurotechnologies: Social obligation or Minority Report? Rockville Science Society Café, Rockville, MD
4. Apr 2012. Neuroweapons: The brain as opportunistic target. Invited speaker: National Academy of Science, Science Entertainment Exchange Symposium, Night of Total Destruction, The Directors’ Guild, Los Angeles, CA.
31. Mar 2012. Neuromorality – implications for global relations and security. Invited speaker: Yale-NY University Moral Brain Conference, New York, NY.
28. Mar 2012. Neurocogniitve techniques and technologies for decision-making augmentation. Plenary and conference co-chair: Office of Naval Research Operational Adaptation Workshop; Washington, DC.
20. Mar 2012. Neurobiologic issues and ethical obligations of bioterrorism disaster response. Invited speaker; FEMA, New York, NY.
16. Mar 2012. Neuroethics- interacting traditions as a form of meta-ethics. Plenary and conference chair: 4th Annual National Neuroscience, Ethics, Legal and Social Issues Conference (NELSI-4), Washington, DC.
24. Feb 2012. Gene, tissue and mechanical brain implants: The medical cyborg? Invited plenary: Convegno della Tecnologie e Diagnostiche della Neuroscienza. University of Torino, Italy.
13. Feb 2012. The putative neuroscience of spiritual experience: Bio-psychosocial manifestations, cultural relevance, and implications for neuroethics. Fulbright Professorship, Oberseminar Lecture Series, Ludwig Maximilians Universität, Munich, Germany.
8. Feb 2012. Neurobioethics: Potential utility as a naturalistic approach to human ecology. Invited lecture: Rachel Carson Center, Ludwig Maximilians Universität, Munich, Germany.
7. Feb 2012. Use of neurotechnology in aerospace medicine: Potential and problems. Invited lecture: Bundeswluftwaffe Luftfahrtsmedizin Programm, Furstenfeldbruck, Germany.
6. Feb 2012. Neuroethics: Two traditions as a plausible meta-ethics? Fulbright Professorship, Oberseminar Lecture Series, Ludwig Maximilians Universität, Munich, Germany.
30. Jan 2012. Neuroscience, neurotechnology and the neuroethical issues focal to caring for Alzheimer’s dementia. Plenary: Robert Bosch Stiftung, Heidelberg, Germany.
27. Jan 2012. Neuroethical issues in the use of brain implant technologies. Plenary: Sfide della Neuroscienza Convegno, Rome, Italy.
14. Dec 2011. Neurotechnology in physiologically individualized longterm operations' training for performance enablement of pilots (PILOT PEP). Invited lecture: International Solar Impulse Project, Zurich/Dubendorf, Switzerland.
6. Dec 2011. Trauma spectrum disorder: Use of neurotechnology in assessment, prevention and treatment, and neuroethical obligations for military medicine. Plenary: NATO-Bundeswehr International Military Mental Health Conference (IMMHC), Berlin, Germany.
5. Dec 2011. From the neuroscience of pain and sentience, to an anti-speciesist neurbioethics? Implications for animal research, regard and artificial intelligence. Fulbright Professorship, Oberseminar Lecture Series, Ludwig Maximilians Universität, Munich, Germany.
30. Nov 2011. Neuro-cognitive technologies in national security, intelligence and defense: Neuroethical obligations and avoiding Icarus’ folly. Invited plenary: First Annual SMA Conference on Neural and Cognitive Sciences in National Security, National Institutes of Health, Bethesda, MD.
28. Nov 2011. The neuroscience of pain and the neuroethical, legal and social issues of pain research and care. Fulbright Professorship, Oberseminar Lecture Series, Ludwig Maximilians Universität, Munich, Germany.
21. Nov 2011. Neuroscience, neurotechnology and psychiatry: Neuroethical issues and concerns in the age of DSM-5. Fulbright Professorship, Oberseminar Lecture Series, Ludwig Maximilians Universität, Munich, Germany.
11. Nov 2011. Transparency and non-transparency in neuroscientific research in national defense agenda: The need for an ethic of responsible parentalism. Invited lecture and panel presentation: International Neuroethics Society Meeting, Washington, DC.
31. Oct 2011. Neurotechnology, pharmaceutics, and the state of pain care in public health. Invited lecture: Emeritus’ Lectures Series: American Public Health Association Meeting, Washington, DC.
20. Oct 2011. Implantable neurotechnologies and neurosecurity: Practical issues and neuroethical considerations. Invited lecture: Cesagen-Universities of Cardiff and Lancaster Joint Workshop on Smart Brain Implants. Welcome Trust Center, London, UK.
13. Oct 2011. Neuroimaging pain: Neuroethical, technical, and socio-legal issues. Invited lecture: Second Annual Reflex Sympathetic Dystrophy Society of America (RSDSA) Conference. Albuquerque, NM.
9. Sept 2011. Icarus’ folly: On the capabilities and limitations of assessment neurotechnologies in national defense. Plenary, CCNELSI Symposium: Potential and Limits of Neuroscientific and Psychiatric Prediction and Prevention of Social Violence. Washington, DC.
22. Aug 2011. Neuroscience and neurotechnology in national security and defense: Ethical, legal and social issues. IGERT Plenary Lecture, University of New Mexico, Albuquerque, NM.
18. Aug 2011. Neurotechnology as neuroweapons in national intelligence, security and defense. Plenary and Co-Chair: PIPS-NDU Conjoint Conference on Neuro-cognitive Sciences and Technology in National Defense: Assessing and Manipulating the Brain, Mind and Social Conduct. Arlington VA.
15. Aug 2011. The neuro-cyber fusion: Issues of stacking, tracking and hacking multi-level data pools. Keynote and Co-Chair: Human Threats in Cybertechnology Conference, National Defense University, Washington, DC.
21. July 2011. Use of neurotechnology in assessing, diagnosing, treating and managing neural spectrum disorders arising from TBI. Invited Lecture: US Navy Surgeon General’s Briefing, Washington, DC.
17. June 2011. The neuroscience of pediatric pain and the neuroethics of pediatric pain care. Keynote: Pain Master Class Symposium; Childrens’ Hospital of Minnesota, Minneapolis, MN.
10. June 2011. What “neuro” really means: On the need for pragmatism, veridicality and intellectual honesty in neuroethics. Keynote: American Philosophical Association Conference on Pragmatism in Neuroscience, Washington, DC.
5. June 2011. The pathology, epidemiology and neuroethical issues of traumatic brain injury: Implications for Navy Medicine. Plenary: US Naval Bureau of Medicine and Surgery Annual Conference, Uniformed Services University of Health Sciences, Bethesda, MD.
27. May 2011. The capabilities and limits of neuroscience, and the need for psychology: Neuroethical obligations and implications. Plenary: American Psychological Society Annual Meeting, Washington, DC.
3. May 2011. Responsible conduct of research – from historicity to canon in practice. Co-chair, Responsible Conduct of Research (RCR) Forum, Gallaudet University, Washington, DC.
25. April 2011. From a neuroscience of pain to a neuroethics of pain care. Invited plenary; First Symposium on Pain; Center for Practical Ethics, University of Kansas, Kansas City, MO.
20. April 2011. Neurotechnology: Capabilities, limits and neuroethical issues. Invited plenary; Grinnell College, Grinnell, IA.
8. Apr 2011. Neuroscience and non-speciesist neuroethics. Invited plenary: Fondazione Caravit Conference: Cervello, Mente ed Etiche, Viterbo, IT.
6. Apr 2011. Neuroethics: Balance and prospective. Invited plenary: European University of Rome, Rome IT.
1. Apr 2011. Scientific convergence in neuroscience: The need for a progressive neuroethics.
Plenary: Third Annual Ethics in Biotechnology Conference, NY Polytechnic Institute, NY, NY.
25 Feb 2011. Chair: National Neuroscience, Ethics and Legal Issues (NELSI-3) Conference: Ethical issues in the use of neuroscience in national security and defense. George Mason University, Fairfax, VA.
11. Feb 2011. Neuroscience, neurotechnology and neuroethics: Confronting the hard problems in practice. Plenary: Dept of Psychiatry; University of Texas SW Medical School, Dallas, TX.
10. Feb 2011. Neuroethics- A naturalistic meta-ethics? Invited lecture: Neuroscience and the future conference, Southern Methodist University Law School, Dallas, TX,
11. Jan 2011. Building brains and manipulating minds: The focus and future of neuroethics. Café Scientifique – National Science Foundation, Arlington, VA.
9. Dec. 2010. Neuroethics: Moral issues from synapse to society. Plenary: Center for Inquiry, Amherst, NY.
9. Dec 2010. Neuroethics: Beyond “the cave” and into the public. Invited lecture: Science and the Public Program, University of Buffalo, NY.
7. Dec 2010. Science and technology: Expectations, aspirations, anxieties – roles and responsibilities of the scientist. Invited lecture: INCBN-IGERT Program, University of New Mexico, Albuquerque, NM.
11. November 2010. Neuroethics: Coming of age and facing the future. Annual Andrej Jus Memorial Lecture. University of Toronto, Toronto, Canada.
1. November 2010. Developmental neurobiology, the neuroscience of pain and analgesia and the neuroethics of pediatric pain care. Washington Area Pediatric Palliative Medicine Conference, Washington, DC.
14. October 2010. Neuropsychiatric issues in pain and addiction: Neuroethical implications in the age of the DSM-5. Scattergood Program for Applied Ethics of Behavioral Health, University of Pennsylvania, Philadelphia, PA.
29. September 2010. Neuroethics- at the intersection of science, sentience and society. Invited plenary: John McGovern Center for Health, Humanities and Ethics, University of Texas Health Sciences Center, Houston, TX.
28. September 2010. Science, ethics and responsibility: Character and conduct. Invited lecture and panelist: Uniformed Services University of the Health Sciences Symposium on Research Ethics, Bethesda, MD.
20. September 2010. Neuroscience, pain and the law. Invited lecture: American Association for the Advancement of Science (AAAS) Judiciary Seminar on Neuroscience and Law. Harvard Law School, Cambridge, MA.
11. September 2010. Narcoterrorism: Foci and casualties in the War on Pain and War on Drugs. Symposium Chair, PainWeek 2010, Las Vegas NV.
8. September 2010. Science and ethics in the cyber-age. Invited lecture and panel discussion. Smithsonian Symposium on Information and Understanding. Smithsonian Institute, Washington, DC.
24. August 2010. Diversity as normalcy: Meaning and practice in research, education and society. William H. and Ruth Crane Schaefer Lecture, Faculty Convocation: Gallaudet University, Washington, DC.
5. August 2010. Are you a cyborg? Neurotechnology as a cultural force. Café Scientifique – NSF Arlington, VA.
7. July 2010. Brain science and social effects- The implications of neuroethics. AmericaEd Conference; Columbia University, NY.
24. June, 2010. Neuroethics: At the intersection of science, society and morality. Invited lecture: Lead America Conference; Georgetown University, Washington, DC.
22. June, 2010. Consciousness: Vistas and challenges of neuroscience, neurotechnology and neuroethics. Keynote, and Chair, Nour Foundation Symposium: Life, Death and the Search for Morality; NY Academy of Sciences, NY.
19. June, 2010. From the neurobiology of pain to a neuroethics of pediatric pain care. Keynote lecture: Third Annual Pediatric Pain Master Class, Children’s' Hospital and Clinics of Minnesota; Minneapolis, MN
14. June 2010. Use of advanced science convergence in diagnosis and treatment of types of mTBI. Plenary lecture: NATO ASI Conference, Chisinau, Moldova.
12. June 2010. Ethical obligations in the use of neuro-nanotechnology in national defense and intelligence applications. Keynote lecture: NATO ASI Conference; Chisinau, Moldova.
15. May 2010. Brain injury as trauma spectrum disorder: Implications for treatment and ethically sound use of biotechnology. US Navy Bureau of Medicine and Surgery, Washington, DC.
9. May 2010: Biotechnology and bio-prediction: Ethical responsibility for prudent stewardship and education. Invited lecture: Wellcome BioPredictions 2010 Conference, Washington, DC.
7. May 2010: Ethical obligations in the use of neuroscience and neurotechnology in national defense. Plenary. Domenici Neuroscience Symposium. Washington, DC.
15 April 2010: Neuroscience, neurotechnology and neuro-ontologies: Implications for d/Deaf-gain and d/Deaf-loss. Plenary; First conference on d/Deaf Gain. Gallaudet University, Washington, D.C.
6. March 2010: Neuroscience and neurotechnology and human flourishing: Contemporary perspectives upon Aquinas Beatitudo. Plenary lecture: Aquinas Symposium on Brain, Mind, Soul and Neuroscience. Blackfriars Hall; University of Oxford, UK
20. February, 2010. Brains, Minds, and Selves: What Is It Like to Be a Bat, and What Does It Matter?: National Capital Area Skeptics, National Science Foundation, Arlington, DC.
21. January 2010: Neuroethical considerations of pain and spirituality. Invited plenary: Georgetown University Medicine and Humanities Group, Washington DC.
20 January 2010: Environment, ecology, economic and ethics: Relation to national security. Invited lecture: “New Green Economy” Conference, Washington, DC.
7. Dec. 2009. Progress in science and technology: Hopes, fears and fixes. Invited lecture: INCBN-IGERT Program, University of New Mexico, Albuquerque, NM.
4. Dec. 2009. Neuroethics: Two traditions at the intersection of mind, meaning and morality. Invited lecture: Hastings Center Board Meeting, NY.
19. Nov. 2009. Research in vulnerable populations: Considerations of “good”, vulnerability and biopower. Co-chair, and invited plenary. Office of Naval Research Symposium on Social Science Research in War-torn Countries. Krasnow Institute for Advanced Studies, Reston, VA.
13. Nov. 2009. Reproductive technology, the neurobiology of pain and suffering, and ethical consideration of their intersection. Invited plenary. National Institutes of Health, Section on Reproductive Endocrinology. Bethesda, MD.
4. Nov 2009. Stem cell use in therapeutics against neurodegenerative disorders. Co-chair, and invited lecture, DARPA-Sandia Workshop on Therapeutic Uses of Neural Stem Cells, Washington, DC.
21 Oct. 2009. Neuroscience of pain and exceptional experiences: Implications for ethics and practice of pediatric pain care. Invited Plenary. Fifth Bi-annual Conference on Pediatric Care, Texas Children’s’ Hospital Center, Houston, TX.
2. Oct. 2009. Neurotechnology: Issues and caveats for national intelligence and defense. Invited lecture. Norwich University Advanced Research Institute, VT.
17. Sept. 2009. Post-traumatic stress: New vistas toward elucidation of a spectrum disorder. Invited plenary. Association of Military Surgeons of the United States (AMSUS), Washington, D.C.
16. Sept 2009. Art in science, and the science of art: Depiction, explanation and understanding in neuroscientific illustration. Invited lecture. Guild of Natural Science Illustrators, Smithsonian Institution, Washington, D.C.
12. Sept. 2009. Neuroscience and the social good. Plenary. Decade of the mind-V Conference, Berlin, Germany.
11. Sept. 2009. Neuroscience as an understanding of relationality. Plenary and chair. Nour Foundation Symposium: Neuroscience and Neurotechnology: Toward a Common Morality. United Nations’, NY. See footage of Part 1 and 2 at the following links: United Nations Pt. 1 and United Nations Pt. 2
9. Sept 2009. Neurotechnology in pain care. Toward an anti-specieisist ethics. Plenary. PainWeek Conference, Las Vegas NV.
4. Sept 2009. Nano-neurotechnology, and the ethics of national security. Invited lecture: Center for National Preparedness. University of Pittsburgh, PA.
25. August 2009. Big issues at the (very) small scale: Nano-neurotechnology and ELSI. Plenary:3rd Annual IGERT Conference, University of New Mexico, Albuquerque, NM.
22. July 2009. Beyond the mereological fallacy. Plenary and chair: Nour Foundation Brain, Mind & the Nature of Being Symposium. Oxford, UK.
10. July 2009. Neuroscience, neurotechnology and the philosophy of psychiatry. LeadAmerica Plenary Lecture, Washington, DC.
28. June 2009. Neurobiology, autonomy and agency: Factors in pediatric palliative care. Childrens’ Hospital Foundation Plenary, Minneapolis, MN.
18. June 2009. Chair and plenary: Traumatic brain disorders: Mechanisms, and approaches to treating a putative spectrum pathology. ONR-BIDMI Science Meeting, Samueli Institute, Alexandria, VA.
8. May 2009. The paradox of neurotechnology: Assessing the issues at the frontiers of knowledge. Plenary, and chair: Nour Foundation Paradox of Neurotechnology Symposium, Washington, DC.
28. Mar 2009. On the nature of mental disorders and meaning for psychiatry. Invited Lecture: Dept of Psychiatry, University of Leicester, UK.
5. Feb 2009. Neuroethik: Probleme und Fragen zwischen Gehirn, Geist und Gessellschaft. Friedrich Wilhelms Invited Lecture; Rheinische Universität, Bonn.
14. Jan 2009. Education applications from understanding the human mind. Invited plenary. Decade of the Mind-4 Conference, Albuquerque, NM.
13. Jan 2009. Neuroethics: Defining the field at the boundaries and frontiers. Meeting Chair, and plenary speaker. Neuroethics, Legal and Social Issues Meeting; Decade of the Mind-4 Conference, Albuquerque, NM.
6 Dec 2008. Neuroethics: Implications for humanity at the intersection of science, technology, and the mind. Psi Chi Plenary; Dept of Psychology, St. Peter’s College, NJ.
5 Dec 2008. The neuroscience of pain: Basis for an anti-specieist neuroethics? Sigma Xi
Plenary; City University of New York, NY
19. Nov 2008. Neuroethics: From theory to practice- implications for education and curriculum. Invited Lecture. Villanova University, Philadelphia, PA.
12 Sept 2008. Neurobiology of neonatal and pediatric pain: Ontogeny and the ethics of agency. Washington Pediatric Hospice Assn, Invited Plenary, Washington, DC
6. Sept 2008. Core philosophy of pain medicine: From neuroscience to neuroethics of pain. Plenary Lecture: PainWeek 2008, Las Vegas NV.
5. Sept 2008. Neural mechanisms of pain and analgesia: From periphery to brain-mind- A role for neruotechonlogy. Plenary lecture: PainWeek 2008, Las Vegas NV.
4. Sept 2008. On the ethical duty to relieve pain. Plenary lecture: PainWeek 2008, Las Vegas NV
30 July 2008. Pain and pain care in pediatric patients: Implications for autonomy, agency and the nature of self. Nemours Childrens’ Hospital, Wilmington DE
22. March 2008. Traumatic brain injury: A putative neuropsychiatric spectrum disorder? Implications for research and ethical obligations of care. NY Academy of Traumatic Brain Injury, Invited Plenary, NYU Hospital, NY.
9. March 2008. Substance abuse: Potential mechanisms of a spectrum disorder. Oxford Roundtable on Science and Healthcare. Lincoln College, University of Oxford, UK
22. October 2007. Placebo effects and responses: neurobiological basis, practical and ethical issues in the spirit of cura personalis. Invited lecture: Dept. of Physiology and Biophysics, Georgetown University Seminar Series, Washington, DC
21. October 2007. Neuroethics: A bigger picture – bottom-up and top-down considerations. Invited panel lecture: American Society of Bioethics and Humanities, Washington, DC
19. September 2007. Body, brain-mind, and spirit: consilient values and virtues in Jesuit education. Invited speaker: Michelmas Convocation, St. Peter’s College, NJ
5. September 2007. From neuroscience to a neuroethics of pain: Implications for constituent disciplines of pain medicine. Invited plenary: American Society of Pain Educators, Las Vegas, NV.
23. June, 2007. Philosophy and ethics of pain management: Concepts, and practical applications toward a unity of brain, mind, meaning and morality in healing. Invited lecture: American Society of Interventional Pain Physicians’ Capitol Hill Meeting, Washington, DC.
11. June 2007 Suffering, the self, and the clinical encounter. George Washington University Hospital, and School of Medicine Grand Rounds, Washington, DC
10. May 2007 Ethical imperatives and obligations for research in CAM: Can a core philosophical basis enable a truly integrative medicine? Plenary: International Congress on Complementary Medicine Research, Munich, GER
7. May 2007 Moral agency in pain medicine. Invited Universum Lecture. Dept of Moral Theology and Philosophy, Universitaet Bonn, Bonn, GER
21 April 2007 At the interface of brain, mind and machine: Neuroethics of neurobiotechnology.
Fourth Annual Conference of Biotechnology, NY Polytechnic Institute-SUNY Downstate Medical College, Brooklyn, NY
14. April 2007 Understanding a neuroscience of suffering to derive an agent-based ethics of medicine. Plenary, Delaware Medical Society Annual Meeting, Wilmington DE.
2. April 2007 New vistas in brain, mind, and healing research: Toward a translational effort ofcura personalis. Invited lecture: Grinnell College, Grinnell IA.
15. March 2007 Science and spirituality: Natural philosophical foundations,
complex systems applications, and preservation of the notion of transcendence. Oxford Roundtable in Science and Religion, Lincoln College, University of Oxford, Oxford, UK.
4. December 2006 Does the neuroscience of pain ground a neuroethics of pain medicine?
Plenary; Ethics in Medicine Series, National Institutes of Health, Bethesda, MD
20. November 2006 Clinical ethics in medicine: Historical perspective, potential and problems for the present and future. Cornell University Symposium on History in Medicine. Washington, DC.
7. September 2006 Beyond the analgesic ladder: Ethical and practical issues in analgesic pharmacotherapeutics and drug development. Plenary Lecture: American Academy of Pain Management Clinical Meeting, Orlando FL.
29. August 2006 Ethical implications for and in infrared imaging biotechnology research and practice. International Biomedical Engineering Society Conference, New York, NY
7. August 2006 Profession, moral obligation and the ethical practice of pain medicine. Plenary lecture, American Society of Interventional Pain Physicians, St. Louis, MO
10 July 2006 Regrounding medicine in humanity amidst technocracy and cultural pluralism: On the need for a philosophy of medicine. Invited lecture; Roundtable in Arts and Sciences, Harris Manchester College, University of Oxford, Oxford, UK
25. June 2006 Placebo and nocebo: Science, evidence and ethics in research and practice. Manchikanti Distinguished Lecture, American Board of Pain Medicine Congressional Meeting, Washington, D.C.
25. May 2006 The problem of pain, and the process and purpose of policy. Invited Lecture: Delaware Medical Society, Wilmington, DE
21. April 2006 From a neuroscience to a neurophilosophy of pain: Implications for ethics in research and practice of pain medicine. Colorado Consortium of Professional Psychology, Colorado Springs, CO
16. March 2006 A right and good healing: Philosophical basis and ethical obligations inherent to medical integration. Plenary Lecture: ACC-Research Advisory Council Conference, Tysons Corner, VA
3. March 2006 Virtue as a bridge to facilitate integration of complementary and mainstream medicine. Association for Professional and Practical Ethics, Jacksonville, FL.
18 February 2006 The neurobiology and neurophilosophy of mind-body interactions: Implications for medical practice and bioethics. CG Jung Center, Houston, TX
17 February 2006 Can the neurobiology of pain contribute to both the neurophilosophy of mind and an ethic of care? University of Texas Health Sciences Center, Houston, TX
16 February 2006 Mechanisms and ethical use of acupuncture as co-opted technique or therapeutic system within an integrated medical model. TIRR, Houston, TX.
28 October 2005 Healing what cannot be cured: The legacy of Albert Schweitzer’s “Reverence for Life” in a contemporary philosophy of medicine. Tenth Annual Albert Schweitzer Memorial Symposium, Albert Schweitzer Center, Quinnipiac University, CT.
7 October 2005 Complementary, but not alternative to medicine: The importance of a core-philosophy and virtue-based ethics to enhance cultural competence and integration of CAM and mainstream medicine. Neiswanger Institute Conference on Medical Education and Cultural Competence, Loyola University, Chicago, IL.
24 September 2005 Neurophilosophy of maldynic pain: Disease, illness and ethical obligations to treatment. Plenary Lecture: American Academy of Pain Management Clinical Meeting, San Diego, CA
9 September 2005 Ethics of pain research and medicine: Neuroscience and the basis of therapeutic and moral agency. Invited Plenary Lecture: American Society of Pain Educators National Forum, Las Vegas, NV
6-7 August 2005 Neuroanatomy and pathophysiology of pain: Toward a reconciliation of disease process and illness phenomenon. Invited plenary lecture: American Society of Interventional Pain Physicians. St Louis, MO
29 June, 2005 Autonomic substrates of neuropathic pain syndromes: Ethical and pragmatic issues in quantification of qualitative variables. Plenary Lecture: American Academy of Thermology, Baton Rouge, LA.
19 March 2005 Ethical obligations defining the need for evidence-based practice of complementary therapeutics an integrative medical model. Research Advisory Committee/ACC, Las Vegas, NV.
9 September, 2004 The role of serotonin 5-HT3 receptors in pain and anti-nociception: A mechanism for channelopathic maldynia and its cognitive effects. American Academy of Pain Management Clinical Meeting, San Antonio, TX
8 August, 2004 Nociceptive and neuropathic pain: anatomy, physiology, iatrogenic factors dictating ethical care. American Society of Interventional Pain Physicians, St. Louis, MO
19 January, 2004 Anatomic, chemical and molecular basis of maldynic pain: physiologic and cognitive neuroscientific relevance to a neurophilosophy of pain. American Academy of Pain Medicine Invited Lecture, Newport, CA
10 September, 2003 Neural mechanisms of pain and analgesia: role of neurologic substrates in determining patient responses: Ethical responsibilities. American Society of Interventional Pain Physicians, Alexandria, VA.
6 September, 2003 Neurobiology of nociception and pain modulation: Novel roles for serotonergic and nitric oxidergic substrates in clinical syndromes. American Academy of Pain Management Clinical Meeting, Denver, CO.
20 August 2003 Phytomedicinal and nutriceutical approaches to managing chronic pain in the sports’ medical setting: Evidence-based approaches and ethical use. Baylor Sports Medicine Institute, Houston, TX.
8 September 2002 Neurochemical basis of type II and type III pain: implications for ethical pharmacotherapeutics. American Academy of Pain Management Clinical Meeting, Reno, NV
19 February, 2002 Utility of sertraline in reducing chronic pain and specific neuroendocrine parameters of fibromylagia. Pfizer Grand Rounds Series Lecture, College Station, TX.
22. January, 2002 Role of serotonin receptors and reuptake sites in mediating the symptomatic constellation in fibromyalgic patients. Pfizer Grand Rounds Series Lecture, Texas Methodist Hospital, Houston, TX
8 January 2002 Forensic neurology in aviation accident reconstruction. FAA Safety Lecture Series, Houston, TX.
1 November 2001 Integrative pain management: A role for complementary and alternative therapeutics, and ethical parameters. Rice University, Houston, TX.
26 October 2001 Pharmacodynamic and kinetic parameters of celecoxib and rofecoxib suggest distinct utility in the treatment of uncomplicated myofascial pain. Texas Medical Association Grand Rounds Meeting, Houston, TX.
23 August 2001 COX-II inhibitors in the treatment of primary myofascial pain syndrome: beyond the RCT. Texas Methodist Hospital Grand Rounds, Houston, TX
19 April 2001 Neuropharmacology of serotonin reuptake sites in brain and spinal cord: implications for pragmatically appropriate and ethically sound use of specific SSRIs for pain based upon pharmacokinetic and dynamic effects. Memorial Hermann Hospital Grand Rounds Lecture, Houston, TX
24 March 2001 The serotonergic system in chronic pain and depression: chemical co-morbidity may indicate pharmacotherapeutic specificity. Pfizer Grand Rounds Series, Methodist Hospital, Houston, TX
13 March 2001 Serotonin receptors in maldynic pain and depressive illness: targets for drug therapy. Harris County Medical Association Meeting, Houston, TX
20 January 2001 Use of biochemical markers in the pharmacotherapeutics of the depressed chronic pain patient. SE Texas Medical Association Meeting, Beaumont, TX
14 June 2000 Neurophysiology of stress factors in high performance aircraft flight. Center for Aviation Safety Education, Embry-Riddle Aeronautical University, Prescott, AZ
8 June 2000 Pain medicine: from research to practice: Ethical implications. Texas Healthcare Network Lecture Series, Houston, TX
9 March 2000 Serotonin receptors in the mediation of migraine headache and atypical cephalalgia. Merck Sharpe-Dohme Grand Rounds Lecture Series, Austin, TX
9 June, 1999 Stress effects on human factors contributory to industrial accidents and pain: Ethical responsibilities for occupational medicine. Texas Chemical Society Conference, Conroe, TX.
19 May, 1999 New developments in psychopharmacology: The ethics of psychogenetics. S.E. Texas Psychological Association, Beaumont, TX.
22 January, 1999 Chronic pain: advances in research, diagnosis and treatment. National Academy of Continuing Education, Jacksonville, FL.
21 January, 1999 Stress factors affecting accident susceptibility and resultant pain. American Society of Safety Engineers Regional Conference, Beaumont, TX.
8 November, 1998 Behavioral medical issues in chronic pain: Ethical issues in pain research and therapy. Grand Rounds, St. Elizabeth’s Hospital, Beaumont, TX.
2 November, 1998 Medical certification for aviators: disease, illness and truth-telling in practice. Greater Houston Association of Flight Instructors’ Conference, Houston, TX.
10 September, 1998 Effective management of human factors dynamics in aviation safety programs. Houston FSDO Aviation Safety Training Course, Houston, TX.
9 July, 1998 Sexual Dysfunction: Diagnoses, pathology and therapy in chronic pain patients. Texas Psychological Association, Beaumont, TX.
4 July, 1998 Human factors in pilot performance. Galveston Area Aviation Society, Dept. Aviation Medicine UTMB, Galveston, TX.
11 February, 1998 Identifying and managing aviation stress factors. S.E. Texas Pilots’ Assn., Beaumont, TX.
14 January, 1998 Personality factors in aviator performance. Beaumont Flight Safety Meeting, Beaumont, TX.
17 December, 1997 Ergonomics and bioengineering in general aviation. S.E. Texas Pilots’ Assn., Houston, TX.
15 November, 1997 Factors in aircraft crash survival. Houston Area Flight Standards and Safety Meeting.
17 October, 1997 Geriatric Pain Management: Teaching old dogma new tricks. Texas Statewide Consortium on Gerontology, Beaumont, TX.
15 August, 1997 The many faces of pain: new vistas in bioethical pain management. Ward Symposium, John Gray Center, Beaumont, TX.
1 February, 1997 Donepezil: a novel agent in treating Alzheimer’s dementia. Alzheimer’s Disease Foundation, Austin, TX.
5 February, 1997 Novel approaches to analgesic pharmacotherapy: Ethical and medico-legal parameters in clinical practice. St. Elizabeth Conference in Advances in Healthcare, Beaumont, TX.
19 February, 1997 Multidisciplinary approaches to chronic pain management. Department of Medicine and Surgery, Jennie Sealy Hospital, UTMB, Galveston, TX.
20 February, 1997 Pathophysiology of Alzheimer’s dementia: utility of donepezil pharmacotherapy. Conference of Beaumont Primary Care Providers/Physicians, Beaumont, TX.
16 November, 1996 Environmental effects on neurogenesis: Implications for nature, nurture and neurology. Texas Perinatal Assn. Annual Conference, Dallas, TX.
26 October, 1996 Myofascial Pain Syndrome: Serotonergic substrates as targets for therapy. S.F. Austin State University Clinical Care Conference, Nacogdoches, TX.
16 July, 1996 Biopsychology of stress responses: practical and bioethical implications for occupational medicine. Integrated Health Care Dept. , E.I. DuPont Co., Beaumont, TX.
4 December, 1995 Putative role of serotonin 5-HT3 receptors in pain and analgesia. Pain Study Section, Roche Biosciences, Palo Alto, CA.
14 October – 18 November, 1995 Exercise Physiology: A role in conservative, chronic pain management. Invited Lecture Series: Pinnacle Health Care, Havelock, NC.
12 October, 1994 Biomechanical implications of Aviator Back Syndrome relevant to Gz-axis impact-acceleration injury susceptibility and pain. Safety and Flight Equipment Conference, Reno, NV.
30 April, 1992 Effects of unusual movement, disorientation, pain and stress on aviator physiology and performance. FAA Medical Safety Seminar, Des Moines, IA.
21 April, 1992 The spinal and peripheral 5-HT receptor system and inflammatory pain: Ontogeny and functional mechanisms. Dept. of Neuroscience, University of Minnesota, Minneapolis, MN.
23 March, 1992 5-HT receptor-mediation of pain and analgesia: new vistas and pharmacologic implications. Depts. of Biophysics and Neuroscience, Allegheny General Hospital Center, Pittsburgh, PA.
12 March, 1992 Central nervous system mechanisms of vertigo and disorientation in aviators: role of 5-HT and 5-HT receptors. FAA Midwest Chapter Seminar, Cedar Rapids, IA.
16 February, 1992 Central and peripheral nervous systems as pharmacological targets for stress and pain management. U.S. Navy Fleet Hospital, Des Moines, IA.
18 November, 1991 Assessment and treatment of pain and stress in research animals: Practical and ethical concerns. Depts. of Pharmacology and Psychiatry, Allegheny-Singer Research Institute, Pittsburgh, PA.
9 September, 1991 Advances in research and therapy of Parkinson’s disease: Confronting bioethical issues in fetal tissue utilization. Iowa Parkinson’s Disease Society, Des Moines, IA.
29 April, 1991 Pharmacologic substrates of pain and pain modulation. Mind and Medicine Annual Lecture Series. Dept. of Pharmacology and Physiology University of Osteopathic Medicine and Health Sciences, Des Moines, IA.
5 March, 1991 Azapirone 5-HT1A agonist effects on CNS and neuroendocrine substrates of analgesia. Mead-Johnson Invited Lecture, Des Moines, IA.
25 February, 1991 Putative mechanisms of azapirone-induced analgesia. Invited Lecture/Grand Rounds, Allegheny-Singer Research Institute, Pittsburgh, PA.
20 November, 1990 Serotonin 5-HT1A and 5-HT3 receptor mediation of nociception. Sigma Xi Distinguished lecture, Iowa State University College of Veterinary Medicine, Ames, IA.
12 November, 1990 Interaction of serotonergic and neuroendocrine systems in pain modulation. Sandoz Colloquium on Somatostatin and Pain, New York, NY.
10 September, 1990 Physio-pharmacology of stress and pain: A shared system of mind and body?. Invited lecture: University of Osteopathic Medicine and Health Science, Des Moines, IA.
20 September, 1990 Novel therapeutic approaches against neurodegenerative disorders: Practicality and ethics. Iowa Parkinson’s Disease Society, Des Moines, IA.
18 August, 1989 Anatomy and pharmacology of antinociceptive systems in neonates: Developmental effects of pharmacotherapy. Grand Rounds Neonatal Intensive Care Unit Iowa Methodist Medical Center, Des Moines, IA.
23 May, 1989 Analgesic systems in the newborn: Practical and ethical implications for pharmacotherapeutics. Iowa Methodist Medical Center: Conference for Pediatric and Neonatal Nursing, Iowa City, IA.
19 April, 1989 Cellular and molecular pharmacology of novel anxiolytic and antidepressant agents. Polk County Mental Health Foundation, Des Moines, IA.
14 April, 1989 Patterns of analgesia produced by the novel anxiolytic buspirone: Implications for clinical utility. Interdisciplinary Conference on Rehabilitative Neurology, Iowa Methodist Foundation, Des Moines, IA.
3 April, 1989 Neuromodulation of spinal and supraspinal analgesic systems in the neonatal rat. Depts. of Physiology and Pharmacology, Iowa State University College of Veterinary Medicine, Ames, IA.
14 September, 1988 Advances in pharmacotherapeutics of opioid abuse. Interdisciplinary Narcotic Control Conference Iowa Governor’s Alliance on Substance Abuse, Des Moines, IA.
9 September, 1988 Pharmacologic mechanisms of narcotic dependence: Perspectives on novel treatment approaches in fetal addictive syndromes. Grand Rounds, Dept. of Pediatrics Blank Hospital, Iowa Methodist Medical Center, Des Moines, IA.
21 August, 1988 Stress-, and exercise-induced alterations in opioid neurochemistry. 1st Symposium on Fitness Medicine, Kansas City, MO.
18 August, 1988 Pharmacologic and genetic mechanisms of substance abuse. Drug Abuse Center, Powell Clinic, Iowa Methodist Medical Center, Des Moines, IA.
10 May, 1988 Pharmacology and development of bulbospinal systems in opiate anti-nociception. Dept. of Pharmacology, Philadelphia College of Pharmacy and Health Sciences, Philadelphia, PA.
1 February, 1988 Changing neuropharmacologic patterns of opioid analgesia in neonatal rats. Depts. of Psychology and Anatomy, University of Rochester, Rochester, NY.
18 October, 1987 Pharmacologic substrates of stimulus-specificity in spinal and supraspinal opioid analgesia. Dept. of Clinical Neuropharmacology, Max Planck Institut fur Psychiatrie, Munich, Germany.